Sumit Sethi1, Mirian A Hayashi1, Alessandra Sussulini2, Ljubica Tasic3, Elisa Brietzke1. 1. a Interdisciplinary Laboratory for Clinical Neuroscience (LiNC), Department of Psychiatry , Universidade Federal De São Paulo - UNIFESP , São Paulo , Brazil. 2. b Department of Analytical Chemistry , Institute of Chemistry, Universidade Estadual De Campinas - UNICAMP , Campinas , SP , Brazil. 3. c Department of Organic Chemistry , Institute of Chemistry, Universidade Estadual De Campinas - UNICAMP , Campinas , SP , Brazil.
Abstract
OBJECTIVES: In this review, the authors discuss an overview of lipidomics followed by in-depth discussion of its application to the study of human diseases, including extraction methods of lipids, analytical techniques and clinical research in neuropsychiatric disorders. METHODS: Lipidomics is a lipid-targeted metabolomics approach aiming at the comprehensive analysis of lipids in biological systems. Recent technological advancements in mass spectrometry and chromatography have greatly enhanced the development and applications of metabolic profiling of diverse lipids in complex biological samples. RESULTS: An effective evaluation of the clinical course of diseases requires the application of very precise diagnostic and assessment approaches as early as possible. In order to achieve this, "omics" strategies offer new opportunities for biomarker identification and/or discovery in complex diseases and may provide pathological pathways understanding for diseases beyond traditional methodologies. CONCLUSIONS: This review highlights the importance of lipidomics for the future perspectives as a tool for biomarker identification and discovery and its clinical application.
OBJECTIVES: In this review, the authors discuss an overview of lipidomics followed by in-depth discussion of its application to the study of human diseases, including extraction methods of lipids, analytical techniques and clinical research in neuropsychiatric disorders. METHODS: Lipidomics is a lipid-targeted metabolomics approach aiming at the comprehensive analysis of lipids in biological systems. Recent technological advancements in mass spectrometry and chromatography have greatly enhanced the development and applications of metabolic profiling of diverse lipids in complex biological samples. RESULTS: An effective evaluation of the clinical course of diseases requires the application of very precise diagnostic and assessment approaches as early as possible. In order to achieve this, "omics" strategies offer new opportunities for biomarker identification and/or discovery in complex diseases and may provide pathological pathways understanding for diseases beyond traditional methodologies. CONCLUSIONS: This review highlights the importance of lipidomics for the future perspectives as a tool for biomarker identification and discovery and its clinical application.
Entities:
Keywords:
Biomarkers; bipolar disorder; lipidomics; major depressive disorder; schizophrenia
Authors: Raissa Lerner; Julia M Post; Shane R Ellis; D R Naomi Vos; Ron M A Heeren; Beat Lutz; Laura Bindila Journal: J Lipid Res Date: 2017-12-05 Impact factor: 5.922
Authors: Liisa Leppik; Madis Parksepp; Sven Janno; Kati Koido; Liina Haring; Eero Vasar; Mihkel Zilmer Journal: Eur Arch Psychiatry Clin Neurosci Date: 2019-01-02 Impact factor: 5.270
Authors: Helena P G Joaquim; Alana C Costa; Leda L Talib; Frederik Dethloff; Mauricio H Serpa; Marcus V Zanetti; Martinus van de Bilt; Christoph W Turck Journal: Front Psychiatry Date: 2020-06-05 Impact factor: 4.157